Malaysia’s healthtech startup Naluri bags $5m in Series A funding
Naluri co-founder, CEO Azran Osman Rani
June 9, 2021
Malaysia-based digital health service provider Naluri Hidup announced on Wednesday the closing of a $5 million Series A funding round.
Besides the cornerstone investor, Singapore’s Integra Partners, other strategic investors who participated in the funding include: Duopharma Biotech Bhd, Pathology Asia (via Biomark), and venture capital firm M Venture Partners, who were part of the company’s preceding round, Naluri said in a statement.
Naluri also added new investors to its cap table Sumitomo Corporation Equity Asia, Palm Drive Capital from New York and INP Capital from Vancouver, Canada. The company also gained support from the Hibiscus Fund, a venture capital fund managed by Malaysia’s RHL Ventures and Korea’s KB Investment that are part of the government’s Dana Penjana National Programme.